Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main objectives of the trial are: (i) to determine whether a low dose of radioactive iodine (1.1 GBq) is as effective as the commonly used high dose (3.7GBq) in ablating any remaining thyroid tissue after surgery (ii) to determine whether taking recombinant human thyroid stimulating hormone (rhTSH) has no adverse effect on radioactive iodine ablation of the thyroid remnant compared to the current practice of withdrawing thyroid hormone 2−4 weeks before radioiodine ablation.
Critère d'inclusion
- Differentiated thyroid cancer (DTC)